acquired resistance to osimertinib in t790m-positive nsclc
Published 7 years ago • 819 plays • Length 2:04Download video MP4
Download video MP3
Similar videos
-
2:30
acquired resistance to osimertinib in egfr nsclc - 2022 program: targeted therapies forum - english
-
3:59
osimertinib for egfr t790m resistance mutations in nsclc
-
3:24
options for egfr mutation-positive patients with t790m mutation-negative acquired resistance
-
13:53
emerging options for t790m-positive acquired resistance
-
5:20
rociletinib/osimertinib for egfr t790m-negative nsclc
-
1:40
dr. ramalingam on the role of osimertinib in egfr t790m-positive advanced nsclc
-
20:07
acquired egfr resistance: what are the current therapeutic strategies?
-
1:06
dr. carbone on acquired resistance to osimertinib in nsclc
-
3:48
mechanisms of resistance to upfront egfr-targeted therapy
-
1:53
resistance to osimertinib in egfr-mutated nsclc
-
1:53
resistance to osimertinib in egfr-mutated nsclc
-
5:29
osimertinib for the t790m resistance mutation
-
3:13
osimertinib responses after rociletinib treatment of t790m-positive nsclc
-
18:44
2020 ttf egfr breakout piotrowska part 2 - current options upon acquired resistance to osimertinib
-
24:36
treatment options for egfr t790m negative acquired resistance
-
2:10
slcvl raez #17 treatment options for acquired resistance to egfr tkis: t790m-negative disease
-
2:26
patterns of acquired resistance to egfr tkis in egfr mutation-positive nsclc
-
3:38
osimertinib and plasma genotyping
-
1:41
dr. goldberg on resistance to osimertinib for nsclc